Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Identification of a Multipotent Progenitor Population in the Spleen That Is Regulated by NR4A1.

Mumau MD, Vanderbeck AN, Lynch ED, Golec SB, Emerson SG, Punt JA.

J Immunol. 2018 Feb 1;200(3):1078-1087. doi: 10.4049/jimmunol.1701250. Epub 2017 Dec 27.

2.

A Career at a Small Liberal Arts College.

Punt J.

Cold Spring Harb Perspect Biol. 2017 Oct 3;9(10). pii: a032789. doi: 10.1101/cshperspect.a032789. Review.

PMID:
28974573
3.

Hamstring Tendon Regeneration After Harvesting: A Systematic Review.

Suijkerbuijk MAM, Reijman M, Lodewijks SJ, Punt J, Meuffels DE.

Am J Sports Med. 2015 Oct;43(10):2591-8. doi: 10.1177/0363546514562169. Epub 2014 Dec 29. Review.

PMID:
25548149
4.

The orphan nuclear receptor NR4A1 specifies a distinct subpopulation of quiescent myeloid-biased long-term HSCs.

Land RH, Rayne AK, Vanderbeck AN, Barlowe TS, Manjunath S, Gross M, Eiger S, Klein PS, Cunningham NR, Huang J, Emerson SG, Punt JA.

Stem Cells. 2015 Jan;33(1):278-88. doi: 10.1002/stem.1852.

5.

NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis.

Hanna RN, Shaked I, Hubbeling HG, Punt JA, Wu R, Herrley E, Zaugg C, Pei H, Geissmann F, Ley K, Hedrick CC.

Circ Res. 2012 Feb 3;110(3):416-27. doi: 10.1161/CIRCRESAHA.111.253377. Epub 2011 Dec 22.

6.

GSK3-mediated instability of tubulin polymers is responsible for the failure of immature CD4+CD8+ thymocytes to polarize their MTOC in response to TCR stimulation.

Cunningham NR, Hinchcliff EM, Kutyavin VI, Beck T, Reid WA, Punt JA.

Int Immunol. 2011 Nov;23(11):693-700. doi: 10.1093/intimm/dxr076. Epub 2011 Sep 20.

7.

The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes.

Hanna RN, Carlin LM, Hubbeling HG, Nackiewicz D, Green AM, Punt JA, Geissmann F, Hedrick CC.

Nat Immunol. 2011 Jul 3;12(8):778-85. doi: 10.1038/ni.2063.

8.

T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Moran AE, Holzapfel KL, Xing Y, Cunningham NR, Maltzman JS, Punt J, Hogquist KA.

J Exp Med. 2011 Jun 6;208(6):1279-89. doi: 10.1084/jem.20110308. Epub 2011 May 23.

9.

Treatment of recurrent central nervous system primitive neuroectodermal tumours in children and adolescents: results of a Children's Cancer and Leukaemia Group study.

Pizer B, Donachie PH, Robinson K, Taylor RE, Michalski A, Punt J, Ellison DW, Picton S.

Eur J Cancer. 2011 Jun;47(9):1389-97. doi: 10.1016/j.ejca.2011.03.004. Epub 2011 Apr 5.

PMID:
21474302
10.

Clinical pharmacokinetics of metformin.

Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, Furlong TJ, Greenfield JR, Greenup LC, Kirkpatrick CM, Ray JE, Timmins P, Williams KM.

Clin Pharmacokinet. 2011 Feb;50(2):81-98. doi: 10.2165/11534750-000000000-00000. Review.

PMID:
21241070
11.

Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.

Grundy RG, Wilne SH, Robinson KJ, Ironside JW, Cox T, Chong WK, Michalski A, Campbell RH, Bailey CC, Thorp N, Pizer B, Punt J, Walker DA, Ellison DW, Machin D; Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee.

Eur J Cancer. 2010 Jan;46(1):120-33. doi: 10.1016/j.ejca.2009.09.013.

PMID:
19818598
12.

Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.

Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J, Cox T, Chong WK, Campbell RH, Bailey CC, Gattamaneni R, Picton S, Thorpe N, Mallucci C, English MW, Punt JA, Walker DA, Ellison DW, Machin D; Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee.

Lancet Oncol. 2007 Aug;8(8):696-705.

PMID:
17644039
13.

Immature CD4+CD8+ thymocytes and mature T cells regulate Nur77 distinctly in response to TCR stimulation.

Cunningham NR, Artim SC, Fornadel CM, Sellars MC, Edmonson SG, Scott G, Albino F, Mathur A, Punt JA.

J Immunol. 2006 Nov 15;177(10):6660-6.

14.

Inflicted head injury in infants: issues arising from the Geddes hypothesis.

Punt J.

Arch Dis Child. 2006 Aug;91(8):714-5. No abstract available.

15.

Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.

Dumortier A, Jeannet R, Kirstetter P, Kleinmann E, Sellars M, dos Santos NR, Thibault C, Barths J, Ghysdael J, Punt JA, Kastner P, Chan S.

Mol Cell Biol. 2006 Jan;26(1):209-20.

16.

Update from the ophthalmology child abuse working party: Royal College ophthalmologists.

Adams G, Ainsworth J, Butler L, Bonshek R, Clarke M, Doran R, Dutton G, Green M, Hodgkinson P, Leitch J, Lloyd C, Luthert P, Parsons A, Punt J, Taylor D, Tehrani N, Willshaw H; Child Abuse Working Party.

Eye (Lond). 2004 Aug;18(8):795-8. Review. No abstract available.

PMID:
15218524
17.

The 'unified hypothesis' of Geddes et al. is not supported by the data.

Punt J, Bonshek RE, Jaspan T, McConachie NS, Punt N, Ratcliffe JM.

Pediatr Rehabil. 2004 Jul-Sep;7(3):173-84. Review.

PMID:
15204569
18.

Surgical management of paediatric stroke.

Punt J.

Pediatr Radiol. 2004 Jan;34(1):16-23. Epub 2003 Dec 2. Review.

PMID:
14652702
19.

Neuroendoscopic third ventriculostomy for failed shunts.

Buxton N, Macarthur D, Robertson I, Punt J.

Surg Neurol. 2003 Sep;60(3):201-3; discussion 203-4.

PMID:
12922033
20.

Intradural cerebellar chordoma in a child: a case report and review of the literature.

Dow GR, Robson DK, Jaspan T, Punt JA.

Childs Nerv Syst. 2003 Mar;19(3):188-91. Epub 2003 Feb 26. Review.

PMID:
12644872
21.

Neuroimaging for non-accidental head injury in childhood: a proposed protocol.

Jaspan T, Griffiths PD, McConachie NS, Punt JA.

Clin Radiol. 2003 Jan;58(1):44-53.

PMID:
12565205
22.

The role of neuroendoscopy in the management of brain tumours.

Macarthur DC, Buxton N, Punt J, Vloeberghs M, Robertson IJ.

Br J Neurosurg. 2002 Oct;16(5):465-70.

PMID:
12498490
23.

Cutting edge: identification of the targets of clonal deletion in an unmanipulated thymus.

Cho HJ, Edmondson SG, Miller AD, Sellars M, Alexander ST, Somersan S, Punt JA.

J Immunol. 2003 Jan 1;170(1):10-3.

24.

Treatment of Chiari malformation, syringomyelia and hydrocephalus by neuroendoscopic third ventriculostomy.

Buxton N, Jaspan T, Punt J.

Minim Invasive Neurosurg. 2002 Dec;45(4):231-4.

PMID:
12494359
25.

Neurosurgical management of paediatric germ cell tumours of the central nervous system--a multi-disciplinary team approach for the new millennium.

Nicholson JC, Punt J, Hale J, Saran F, Calaminus G; Germ Cell Tumour Working Groups of the United Kingdom Children's Cancer Study Group (UKCCSG) and International Society of Paediatric Oncology (SIOP).

Br J Neurosurg. 2002 Apr;16(2):93-5. No abstract available.

PMID:
12046745
26.

An invitation to T and more: notch signaling in lymphopoiesis.

Allman D, Punt JA, Izon DJ, Aster JC, Pear WS.

Cell. 2002 Apr;109 Suppl:S1-11. Review.

27.

Deciphering the role of Notch signaling in lymphopoiesis.

Izon DJ, Punt JA, Pear WS.

Curr Opin Immunol. 2002 Apr;14(2):192-9. Review.

PMID:
11869892
28.

The intracranial complications of rhinosinusitis: can they be prevented?

Jones NS, Walker JL, Bassi S, Jones T, Punt J.

Laryngoscope. 2002 Jan;112(1):59-63.

PMID:
11802039
29.

Differential requirement for SLP-76 domains in T cell development and function.

Myung PS, Derimanov GS, Jordan MS, Punt JA, Liu QH, Judd BA, Meyers EE, Sigmund CD, Freedman BD, Koretzky GA.

Immunity. 2001 Dec;15(6):1011-26.

30.

The effectiveness of neuroendoscopic interventions in children with brain tumours.

Macarthur DC, Buxton N, Vloeberghs M, Punt J.

Childs Nerv Syst. 2001 Oct;17(10):589-94.

PMID:
11685520
31.

The use of chemotherapy to facilitate surgical resection in pleomorphic xanthoastrocytoma: experience in a single case.

Cartmill M, Hewitt M, Walker D, Lowe J, Jaspan T, Punt J.

Childs Nerv Syst. 2001 Sep;17(9):563-6.

PMID:
11585332
32.

A tale of T-cell tubulin.

Punt J, Owen J.

Trends Immunol. 2001 Aug;22(8):419-20. No abstract available.

PMID:
11473825
33.

Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells.

Allman D, Karnell FG, Punt JA, Bakkour S, Xu L, Myung P, Koretzky GA, Pui JC, Aster JC, Pear WS.

J Exp Med. 2001 Jul 2;194(1):99-106.

34.

The flip side of Fas.

Owen J, Punt J.

Trends Immunol. 2001 May;22(5):241. No abstract available.

PMID:
11323274
35.

Neuroendoscopic third ventriculostomy for hydrocephalus in adults: report of a single unit's experience with 63 cases.

Buxton N, Ho KJ, Macarthur D, Vloeberghs M, Punt J, Robertson I.

Surg Neurol. 2001 Feb;55(2):74-8.

PMID:
11301084
36.

Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength.

Izon DJ, Punt JA, Xu L, Karnell FG, Allman D, Myung PS, Boerth NJ, Pui JC, Koretzky GA, Pear WS.

Immunity. 2001 Mar;14(3):253-64.

37.

Double break-point in the match for the mutator.

Owen JA, Punt JA.

Trends Immunol. 2001 Feb;22(2):69. No abstract available.

PMID:
11286698
38.

Neurological deterioration years after closure of myelomeningocoele - 'the second lesion'.

Macarthur DC, Punt JA, Spencer M, Douglas DL, White BD, Holland IM.

Spinal Cord. 2001 Jan;39(1):11-4. No abstract available.

PMID:
11224008
39.

Third ventricular cysts and membranes unsuspected on conventional CT and MRI.

MacArthur DC, Robertson IJ, Punt JA.

Br J Neurosurg. 2000 Oct;14(5):455-7.

PMID:
11198767
40.

Life rafts for thymocytes

Punt JA.

Immunol Today. 2000 Nov;21(11):530-1. No abstract available.

PMID:
11094253
41.

Immature CD4+CD8+ thymocytes do not polarize lipid rafts in response to TCR-mediated signals.

Ebert PJ, Baker JF, Punt JA.

J Immunol. 2000 Nov 15;165(10):5435-42.

42.

More radiotherapy resources are needed for children as well as adults.

Punt J, Walker D, Sokal M.

BMJ. 2000 May 13;320(7245):1342-3. No abstract available.

43.

Paediatric brain tumours: an embryological perspective.

Scotting PJ, Thompson SL, Punt JA, Walker DA.

Childs Nerv Syst. 2000 May;16(5):261-7; discussion 268. Review.

PMID:
10883369
44.

Terminal Myelocystocele:an unusual presentation.

Cartmill M, Jaspan T, Punt J.

Pediatr Neurosurg. 2000 Feb;32(2):83-5.

PMID:
10838506
45.

Cerebral infarction after neuroendoscopic third ventriculostomy: case report.

Buxton N, Punt J.

Neurosurgery. 2000 Apr;46(4):999-1001; discussion 1001-2.

PMID:
10764279
46.

Assessing apoptosis of developing T cells by flow cytometry.

Bishop CD, Jost A, Crane E, Punt JA.

Methods Mol Biol. 2000;134:117-31. No abstract available.

PMID:
10730253
47.

Standardized quantitative assessment of brain tumor survivors treated within clinical trials in childhood.

Glaser A, Kennedy C, Punt J, Walker D.

Int J Cancer Suppl. 1999;12:77-82.

PMID:
10679875
48.

Flexible neuroendoscopic treatment of suprasellar arachnoid cysts.

Buxton N, Vloeberghs M, Punt J.

Br J Neurosurg. 1999 Jun;13(3):316-8.

PMID:
10562845
49.

Expression of the Bcl-2 family member A1 is developmentally regulated in T cells.

Tomayko MM, Punt JA, Bolcavage JM, Levy SL, Allman DM, Cancro MP.

Int Immunol. 1999 Nov;11(11):1753-61.

PMID:
10545479
50.

Receptor avidity and costimulation specify the intracellular Ca2+ signaling pattern in CD4(+)CD8(+) thymocytes.

Freedman BD, Liu QH, Somersan S, Kotlikoff MI, Punt JA.

J Exp Med. 1999 Oct 4;190(7):943-52.

Supplemental Content

Support Center